vs
Side-by-side financial comparison of Organon & Co. (OGN) and Roper Technologies (ROP). Click either name above to swap in a different company.
Roper Technologies is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× Organon & Co.). Roper Technologies runs the higher net margin — 15.8% vs -13.6%, a 29.4% gap on every dollar of revenue. On growth, Roper Technologies posted the faster year-over-year revenue change (11.3% vs -5.3%). Roper Technologies produced more free cash flow last quarter ($507.0M vs $96.0M). Over the past eight quarters, Roper Technologies's revenue compounded faster (10.5% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Roper Technologies, Inc. is a holding company that owns companies in the technology sector.
OGN vs ROP — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $2.1B |
| Net Profit | $-205.0M | $331.0M |
| Gross Margin | 49.2% | 69.4% |
| Operating Margin | -9.8% | 27.2% |
| Net Margin | -13.6% | 15.8% |
| Revenue YoY | -5.3% | 11.3% |
| Net Profit YoY | -288.1% | 53.7% |
| EPS (diluted) | $-0.78 | $4.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.6B | $2.0B | ||
| Q2 25 | $1.6B | $1.9B | ||
| Q1 25 | $1.5B | $1.9B | ||
| Q4 24 | $1.6B | $1.9B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.6B | $1.7B |
| Q1 26 | — | $331.0M | ||
| Q4 25 | $-205.0M | $428.4M | ||
| Q3 25 | $160.0M | $398.5M | ||
| Q2 25 | $145.0M | $378.3M | ||
| Q1 25 | $87.0M | $331.1M | ||
| Q4 24 | $109.0M | $462.3M | ||
| Q3 24 | $359.0M | $367.9M | ||
| Q2 24 | $195.0M | $337.1M |
| Q1 26 | — | 69.4% | ||
| Q4 25 | 49.2% | 69.5% | ||
| Q3 25 | 53.5% | 69.5% | ||
| Q2 25 | 54.8% | 69.2% | ||
| Q1 25 | 55.6% | 68.7% | ||
| Q4 24 | 56.3% | 68.3% | ||
| Q3 24 | 58.3% | 69.2% | ||
| Q2 24 | 58.4% | 69.5% |
| Q1 26 | — | 27.2% | ||
| Q4 25 | -9.8% | 28.6% | ||
| Q3 25 | 15.2% | 28.4% | ||
| Q2 25 | 14.4% | 28.2% | ||
| Q1 25 | 6.7% | 27.9% | ||
| Q4 24 | 8.1% | 28.0% | ||
| Q3 24 | 13.1% | 28.1% | ||
| Q2 24 | 14.6% | 28.8% |
| Q1 26 | — | 15.8% | ||
| Q4 25 | -13.6% | 20.8% | ||
| Q3 25 | 10.0% | 19.8% | ||
| Q2 25 | 9.1% | 19.5% | ||
| Q1 25 | 5.8% | 17.6% | ||
| Q4 24 | 6.8% | 24.6% | ||
| Q3 24 | 22.7% | 20.8% | ||
| Q2 24 | 12.1% | 19.6% |
| Q1 26 | — | $4.87 | ||
| Q4 25 | $-0.78 | $3.97 | ||
| Q3 25 | $0.61 | $3.68 | ||
| Q2 25 | $0.56 | $3.49 | ||
| Q1 25 | $0.33 | $3.06 | ||
| Q4 24 | $0.42 | $4.29 | ||
| Q3 24 | $1.38 | $3.40 | ||
| Q2 24 | $0.75 | $3.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $382.9M |
| Total DebtLower is stronger | $8.6B | $9.7B |
| Stockholders' EquityBook value | $752.0M | $18.8B |
| Total Assets | $12.9B | $34.6B |
| Debt / EquityLower = less leverage | 11.49× | 0.52× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $382.9M | ||
| Q4 25 | $574.0M | $297.4M | ||
| Q3 25 | $672.0M | $320.0M | ||
| Q2 25 | $599.0M | $242.4M | ||
| Q1 25 | $547.0M | $372.8M | ||
| Q4 24 | $675.0M | $188.2M | ||
| Q3 24 | $763.0M | $269.6M | ||
| Q2 24 | $704.0M | $251.5M |
| Q1 26 | — | $9.7B | ||
| Q4 25 | $8.6B | $9.3B | ||
| Q3 25 | $8.8B | — | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | $7.6B | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — |
| Q1 26 | — | $18.8B | ||
| Q4 25 | $752.0M | $19.9B | ||
| Q3 25 | $906.0M | $20.0B | ||
| Q2 25 | $733.0M | $19.6B | ||
| Q1 25 | $542.0M | $19.2B | ||
| Q4 24 | $472.0M | $18.9B | ||
| Q3 24 | $493.0M | $18.5B | ||
| Q2 24 | $144.0M | $18.1B |
| Q1 26 | — | $34.6B | ||
| Q4 25 | $12.9B | $34.6B | ||
| Q3 25 | $13.6B | $34.6B | ||
| Q2 25 | $13.5B | $33.2B | ||
| Q1 25 | $13.2B | $31.4B | ||
| Q4 24 | $13.1B | $31.3B | ||
| Q3 24 | $12.8B | $31.6B | ||
| Q2 24 | $12.2B | $29.8B |
| Q1 26 | — | 0.52× | ||
| Q4 25 | 11.49× | 0.47× | ||
| Q3 25 | 9.74× | — | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | 0.40× | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | — |
| Free Cash FlowOCF − Capex | $96.0M | $507.0M |
| FCF MarginFCF / Revenue | 6.4% | 24.2% |
| Capex IntensityCapex / Revenue | 3.0% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $141.0M | $738.0M | ||
| Q3 25 | $264.0M | $869.5M | ||
| Q2 25 | $220.0M | $404.1M | ||
| Q1 25 | $75.0M | $528.7M | ||
| Q4 24 | $390.0M | $722.2M | ||
| Q3 24 | $141.0M | $755.4M | ||
| Q2 24 | $332.0M | $384.1M |
| Q1 26 | — | $507.0M | ||
| Q4 25 | $96.0M | — | ||
| Q3 25 | $218.0M | — | ||
| Q2 25 | $181.0M | — | ||
| Q1 25 | $43.0M | — | ||
| Q4 24 | $335.0M | — | ||
| Q3 24 | $99.0M | — | ||
| Q2 24 | $300.0M | — |
| Q1 26 | — | 24.2% | ||
| Q4 25 | 6.4% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 18.7% | — |
| Q1 26 | — | 0.5% | ||
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 2.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.72× | ||
| Q3 25 | 1.65× | 2.18× | ||
| Q2 25 | 1.52× | 1.07× | ||
| Q1 25 | 0.86× | 1.60× | ||
| Q4 24 | 3.58× | 1.56× | ||
| Q3 24 | 0.39× | 2.05× | ||
| Q2 24 | 1.70× | 1.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
